Phio Pharmaceuticals(PHIO) - 2023 Q4 - Annual Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) PHIO PHARMACEUTICALS CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 45-3215903 (I.R.S. Employer Identification No.) 11 Apex Drive, Suite 300A PMB 2006, Marlborough, Massachusetts 01752 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ...